PRIMARY PULMONARY-HYPERTENSION IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - PARTIAL IMPROVEMENT WITH CYCLOPHOSPHAMIDE

被引:0
|
作者
GROEN, H
BOOTSMA, H
POSTMA, DS
KALLENBERG, CGM
机构
[1] UNIV GRONINGEN HOSP,DEPT INTERNAL MED,DIV PULMONOL,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,DEPT INTERNAL MED,DIV CLIN IMMUNOL,9713 EZ GRONINGEN,NETHERLANDS
关键词
PULMONARY HYPERTENSION; CYCLOPHOSPHAMIDE; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension was diagnosed in a patient with SLE after her 5th delivery. Time of onset and absence of thromboembolism and severe interstitial lung disease suggested primary pulmonary hypertension. Administration of vasodilators did not decrease pulmonary artery pressure which amounted to 82/30 mm Hg. Cyclophosphamide infusions, 0.5 g/M2 monthly for 6 months followed by once/3 months, in combination with 7.5 mg prednisolone daily resulted in decrease of pulmonary artery pressure to 66/34 mm Hg after 6 months of treatment persisting for 30 months. Intermittent infusions of cyclophosphamide with low dose prednisolone may be effective in primary pulmonary hypertension in SLE, suggesting an immune mediated pathogenesis.
引用
收藏
页码:1055 / 1057
页数:3
相关论文
共 50 条
  • [41] SYSTEMIC LUPUS-ERYTHEMATOSUS, PULMONARY-HYPERTENSION AND ADULT RESPIRATORY-DISTRESS SYNDROME (ARDS)
    ASHERSON, RA
    RIDLEY, M
    FLETCHER, CDM
    HUGHES, GRV
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1988, 6 (03) : 301 - 304
  • [42] PULMONARY-HYPERTENSION AND CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH THE LUPUS ANTICOAGULANT
    ASHERSON, RA
    MORGAN, SH
    HARRIS, N
    GHARAVI, AE
    HUGHES, GRV
    MILLAR, AB
    ARTHRITIS AND RHEUMATISM, 1985, 28 (01): : 118 - 118
  • [43] PLEXOGENIC PULMONARY-HYPERTENSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - REPORT OF 2 CASES AND REVIEW OF THE LITERATURE
    GOLDMAN, J
    EDWARDS, WD
    CARDIOVASCULAR PATHOLOGY, 1994, 3 (01) : 65 - 69
  • [44] PULMONARY-HYPERTENSION IN SYSTEMIC LUPUS-ERYTHEMATOSUS - TREATMENT WITH HIGH-DOSE NIFEDIPINE THERAPY
    MACHET, L
    CALLENS, A
    MACHET, MC
    DESVEAUX, B
    VAILLANT, L
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1993, 18 (05) : 486 - 487
  • [45] PULMONARY ARTERIAL-HYPERTENSION AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    BUSSIERE, JL
    RISTORI, JM
    LEBLANC, B
    EPIFANIE, JL
    PAILLONCY, M
    NOUVELLE PRESSE MEDICALE, 1981, 10 (13): : 1074 - 1074
  • [46] CYCLOPHOSPHAMIDE IN HEMATOLOGICAL SYSTEMIC LUPUS-ERYTHEMATOSUS
    MILLIGAN, DW
    DELAMORE, IW
    BRITISH MEDICAL JOURNAL, 1982, 285 (6351): : 1352 - 1352
  • [47] PULMONARY VENOOCCLUSIVE DISEASE IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    KISHIDA, Y
    KANAI, Y
    KURAMOCHI, S
    HOSODA, Y
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (12) : 2161 - 2162
  • [48] PULMONARY-HYPERTENSION AND SYSTEMIC ERYTHEMATOSUS
    MORNEX, JF
    ZHANG, HF
    BRUNE, J
    LYON MEDICAL, 1982, 247 (02): : 49 - 51
  • [49] PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    TORBETT, MP
    ERVIN, JC
    AMERICAN JOURNAL OF NURSING, 1977, 77 (08) : 1299 - 1302
  • [50] PULMONARY-ARTERY HYPERTENSION DURING SYSTEMIC LUPUS-ERYTHEMATOSUS
    HAAS, C
    LOWENSTEIN, W
    CAILLAT, P
    DURAND, H
    ANNALES DE MEDECINE INTERNE, 1990, 141 (04): : 340 - 344